Literature DB >> 21901441

The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection.

Behzad Nasiri Ahmadabadi1, Gholamhossein Hassanshahi, Mohammad Kazemi Arababadi, Cristiana Leanza, Derek Kennedy.   

Abstract

Occult hepatitis B infection (OBI) is characterized as a form of hepatitis in which detectable amounts of HBV-DNA can be monitored in the peripheral blood of patients whereas the hepatitis B surface antigen is undetectable. The main aim of this study was to investigate whether there is a relationship between OBI and single nucleotide polymorphisms in the -592 region of the IL-10 gene. In this study, the polymorphism at position -592 of the IL-10 promoter of 57 OBI cases was compared and correlated to that of 100 healthy controls by PCR-RFLP techniques. Our results showed that patient and control groups had significant differences regarding genotypes and alleles of the -592 polymorphism in the IL-10 gene. Based on our results, it can be concluded that the -592 polymorphism within the promoter of the IL-10 gene is associated with OBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21901441     DOI: 10.1007/s10753-011-9381-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  16 in total

Review 1.  Occult hepatitis B: clinical implications and treatment decisions.

Authors:  Paul Schmeltzer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection.

Authors:  Yong-liang Lu; Xiao Wu; Hui-lian Huang; Li-cheng Dai
Journal:  Chin Med J (Engl)       Date:  2010-05-20       Impact factor: 2.628

3.  Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran.

Authors:  Mohammad Kazemi Arababadi; Mohammad Reza Mirzaei; Seyed Mohammad Ali Sajadi; Gholamhossein Hassanshahi; Behzad Nasiri Ahmadabadi; Vajihe Akbarpour Salehabadi; Reza Derakhshan; Derek Kennedy
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 4.  Occult hepatitis B virus infection: a covert operation.

Authors:  F B Hollinger; G Sood
Journal:  J Viral Hepat       Date:  2009-12-09       Impact factor: 3.728

5.  [Study on the association of IL-10-592 polymorphism with susceptibility to hepatitis B viral infection in Han, Yi and Yao ethnic groups in Guizhou province].

Authors:  Chan-Juan Wang; Ke-Ren Shan; Yan He; Ting Zhang; Yi Li; Xiao-Lan Qi; Yan Zhao; Yan Xiao; Chang-Xue Wu; Zhi-Zhong Guan; Xi-Lin Ren
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2008-05

6.  The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.

Authors:  Mehmet Demir; Ender Serin; Savaş Göktürk; Nevin Akcaer Ozturk; Sevsen Kulaksizoglu; Uğur Ylmaz
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-07       Impact factor: 2.566

7.  Polymorphisms of some cytokines and chronic hepatitis B and C virus infection.

Authors:  Qiu-Ju Gao; Dian-Wu Liu; Shi-Yong Zhang; Min Jia; Li-Min Wang; Li-Hong Wu; Shu-Yun Wang; Li-Xin Tong
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Authors:  Alessandro Zerbini; Massimo Pilli; Carolina Boni; Paola Fisicaro; Amalia Penna; Paola Di Vincenzo; Tiziana Giuberti; Alessandra Orlandini; Giuseppina Raffa; Teresa Pollicino; Giovanni Raimondo; Carlo Ferrari; Gabriele Missale
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

Review 9.  Transfusion-transmitted hepatitis B virus infection.

Authors:  Daniel Candotti; Jean-Pierre Allain
Journal:  J Hepatol       Date:  2009-06-10       Impact factor: 25.083

10.  Non-association of IL-12 +1188 and IFN-γ +874 polymorphisms with cytokines serum level in occult HBV infected patients.

Authors:  Mohammad K Arababadi; Ali A Pourfathollah; Abdollah Jafarzadeh; Gholamhossein Hassanshahi; Saeed Daneshmandi; Ali Shamsizadeh; Derek Kennedy
Journal:  Saudi J Gastroenterol       Date:  2011 Jan-Feb       Impact factor: 2.485

View more
  15 in total

Review 1.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

2.  Effect of interleukin-2 level and genetic variants on coronary artery disease.

Authors:  Ru Ding; Wenwu Gao; David H Ostrodci; Zhiqing He; Yuanlin Song; Lan Ma; Chun Liang; Zonggui Wu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

3.  Mutations associated with occult hepatitis B in HIV-positive South Africans.

Authors:  Eleanor A Powell; Maemu P Gededzha; Michael Rentz; Nare J Rakgole; Selokela G Selabe; Tebogo A Seleise; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Med Virol       Date:  2014-08-27       Impact factor: 2.327

4.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

Review 5.  TLR3 plays significant roles against hepatitis B virus.

Authors:  Masoud Karimi-Googheri; Mohammad Kazemi Arababadi
Journal:  Mol Biol Rep       Date:  2014-01-30       Impact factor: 2.316

6.  Effects of interleukin 10 polymorphisms on the development of hepatitis B virus infection: a systemic review and meta-analysis.

Authors:  Chi Shu; Jiarong Wang; Yazhou He; Tiange Song; Zhiyuan Chen; Siqi Tang; Xueyang Tang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  No correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome.

Authors:  Masoomeh Sofian; Ebrahim Kalantar; Arezoo Aghakhani; Soudabeh Hosseini; Mohammad Banifazl; Ali Eslamifar; Ali Jourabchi; Ali Asghar Farazi; Amitis Ramezani
Journal:  Hepat Mon       Date:  2013-05-19       Impact factor: 0.660

8.  The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome.

Authors:  Amitis Ramezani; Mohammad Banifazl; Setareh Mamishi; Masoomeh Sofian; Ali Eslamifar; Arezoo Aghakhani
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

9.  Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins.

Authors:  Seyed Hossein Abdollahi; Fateme Ayoobi; Hossein Khorramdelazad; Behzad Nasiri Ahmadabadi; Mohammadtaghi Rezayati; Mohammad Kazemi Arababadi; Mohammad Zare-Bidaki
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

10.  High Serum Levels of TGF-β in Iranians With Chronic HBV Infection.

Authors:  Hossein Khorramdelazad; Gholamhossein Hassanshahi; Behzad Nasiri Ahmadabadi; Mohammad Kazemi Arababadi
Journal:  Hepat Mon       Date:  2012-11-05       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.